Nalaganje...
Targeting the arginine metabolic brake enhances immunotherapy for leukaemia
Therapeutic approaches which aim to target Acute Myeloid Leukaemia through enhancement of patients’ immune responses have demonstrated limited efficacy to date, despite encouraging preclinical data. Examination of AML patients treated with azacitidine (AZA) and vorinostat (VOR) in a Phase II trial,...
Shranjeno v:
| izdano v: | Int J Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Inc.
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6767531/ https://ncbi.nlm.nih.gov/pubmed/30485425 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.32028 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|